$4.71
0.0551.18%
At close: Nov 13, 4:00 PM EST
Champions Oncology Inc
CSBRNASDAQ
Champions Oncology fell 30.3% from $6.75 to $4.71, behind the S&P 500's +13.3%. Its worst day was Dec 16 (−13.7%), and its low came Oct 19 at $4.69.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.06 beat the $0.01 estimate on $15.0M revenue (est. $14.0M).
−13.7%, the year's worst day · S&P 500 −0.3%
Champions Oncology shares rose 12.6%, while the S&P 500 rose 0.4%.
Story events cover the past 12 months · Times ET
+12.6% · S&P 500 +0.4%
EPS of $0.04 missed the $0.09 estimate on $16.6M revenue (est. $16.6M).
+7.8% · S&P 500 −0.6%
Champions Oncology shares rose 12.4%, while the S&P 500 rose 1.7%.
+12.4% · S&P 500 +1.7%
Champions Oncology shares rose 9.0%, while the S&P 500 fell 0.7%.
+9.0% · S&P 500 −0.7%
EPS of $0.01 beat the $-0.05 estimate on $13.8M revenue (est. $12.9M).
−11.2% · S&P 500 +0.2%
EPS of $0.05 was reported on $15.2M revenue.
0.0% · S&P 500 +0.9%
Champions Oncology closed at its lowest level of the year, 30.5% below where the year started.
−0.2% · S&P 500 +0.4%
Where it ended: a close of $4.71 on Nov 13, 2026. Up next: Q2 2027 earnings on Dec 14, 2026.
Nothing in the past 12 months.
All CSBR analyst actionsNothing in the past 12 months.
All CSBR dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CSBR and SPY from Benzinga historical bars. Not investment advice.
